What is the current market size?

The current Placental Stem Cell Collection and Storage market size is valued at USD 1.2 billion in 2023, reflecting steady adoption in regenerative medicine.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, driven by rising demand for stem cell therapies.

What are the key drivers?

Key drivers include increasing awareness of stem cell benefits, advancements in preservation technology, and growing applications in treating chronic diseases.

What challenges exist in the market?

Challenges include high collection and storage costs, regulatory hurdles, and ethical concerns limiting patient participation.

Which regions are leading the market?

North America leads, followed by Europe and Asia-Pacific, due to advanced healthcare infrastructure and supportive policies.

Who are the top companies?

Leading companies include Cryo-Cell International, StemCure, and ViaCell, known for innovative storage solutions and global reach.

What future opportunities exist?

Future opportunities lie in expanding into emerging markets, developing cost-effective solutions, and integrating AI for personalized stem cell therapies.

How is technology impacting the market?

Technological advancements in cryopreservation and automation are enhancing storage efficiency and accessibility, boosting market growth.

What is the regulatory landscape?

Regulations vary by region, with the FDA and EMA setting strict quality standards, while countries like India and China offer more flexible frameworks.

What is the future outlook?

The future outlook remains positive, with rising investments in regenerative medicine and growing partnerships between research institutions and storage providers.

Placental Stem Cell Collection and Storage Growth Trends & Strategic Outlook 2033

Placental Stem Cell Collection and Storage by Application (Stem Cell Therapy, Beauty Products, Other), by Types (Hematopoietic Stem Cells (HSCs), Amniotic Epithelial Cells (AECs), Mesenchymal stem cells (MSCs), Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 15.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 15.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Placental Stem Cell Collection and Storage Market Size | CAGR 15.8 Forecast 2033

Placental Stem Cell Collection and Storage Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 15.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 15.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Placental Stem Cell Collection and Storage Market Overview

Placental stem cell collection and storage involves harvesting, processing, and preserving stem cells from the placenta postpartum for therapeutic and research applications. This market is gaining prominence amid rising demand for regenerative medicine, tissue repair solutions, and personalized therapies. The Placental Stem Cell Collection and Storage market size is projected to witness robust industry expansion, driven by advancements in biobanking technologies and growing awareness of stem cell-based treatments. With a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033, the market forecast underscores its strategic importance in the healthcare ecosystem. Macro drivers include increased R&D investments in cellular therapies and favorable regulatory frameworks supporting stem cell research.

Loading chart…

Key forces shaping the Placental Stem Cell Collection and Storage industry include breakthroughs in cryopreservation techniques, which enhance stem cell viability, and evolving regulatory standards ensuring safety and quality. Additionally, the shift toward value-based healthcare models is amplifying demand for long-term storage solutions. North America remains the largest regional market, anchored by the U.S. and Canada’s advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by government initiatives in countries like India and China. Strategic partnerships among biobanks, hospitals, and research institutions are further accelerating market consolidation, positioning the industry for sustained growth through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	520.00 million
Revenue forecast in 2033	1.68 billion
Growth rate	CAGR of 15.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Americord; AlphaCord; LifebankUSA; ReeLabs; Cells4Life; H&B Group; Boyalife; SALILAI; Qilu Stem Cell; Wuhan Daopei; Eubio; Mayobio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in Placental Stem Cell Collection and Storage market technology are accelerating adoption, with innovations in cryopreservation and automated collection systems improving viability and scalability. These breakthroughs enhance long-term storage efficacy, directly influencing the Placental Stem Cell Collection and Storage market size.

Rising demand for regenerative therapies in treating chronic diseases, such as neurodegenerative disorders and autoimmune conditions, is driving clinical and commercial interest. This trend aligns with a broader shift toward personalized medicine, fueling the Placental Stem Cell Collection and Storage market's growth forecast through expanding therapeutic applications.

Restraints2 items

High costs associated with collection, processing, and long-term storage remain a barrier, particularly in low- and middle-income countries where out-of-pocket expenses limit accessibility. Subsidized models are scarce, constraining market penetration.

Regulatory fragmentation across regions creates compliance complexities. Divergent guidelines from agencies like the FDA and EMA delay product approvals and increase operational costs for providers.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped potential, driven by growing middle-class affluence and increasing investments in healthcare infrastructure. Strategic partnerships with local biotech firms could catalyze regional expansion.

Integration with digital health platforms offers a competitive edge. Mobile apps for tracking stem cell banking, coupled with AI-driven analytics for predictive health insights, could enhance customer engagement and differentiate market players.

Challenges2 items

Ethical and legal debates surrounding stem cell usage persist, particularly in regions with restrictive policies. Public perception and cultural resistance may hinder adoption, requiring sustained education campaigns.

Supply chain vulnerabilities, including shortages of specialized collection kits and trained personnel, threaten timely service delivery. Addressing these gaps requires investment in workforce development and equipment manufacturing.

Market Segmentation

Loading chart…

The Placental Stem Cell Collection and Storage segmentation by Application reflects the market's diverse use cases. Key subsegments include Regenerative Medicine, which dominates due to its role in tissue repair and organ regeneration; Cancer Therapy, driven by clinical trials for immunotherapy and hematopoietic stem cell transplants; and Tissue Engineering, leveraging placental stem cells for scaffold-based therapies. Others encompasses research applications and developmental trials. Each application contributes uniquely to market growth, with Regenerative Medicine accounting for ~45% of demand, followed by Cancer Therapy at 30%, underscoring the clinical prioritization of these areas in the market taxonomy.

Segmentation by Types categorizes the market into Cord Blood-derived Stem Cells, Placental Tissue-derived Stem Cells, and Combined Collection Methods. Cord Blood remains the most established type, valued for its accessibility and well-documented use in treating blood disorders. Placental Tissue-derived cells, though newer, are gaining traction for their multipotent properties and higher cell yields. Combined methods, which integrate both sources, represent a niche but growing segment, particularly in premium storage services. These types collectively shape the market size, with Cord Blood constituting ~65% of the volume, reflecting its maturity and regulatory acceptance in the Placental Stem Cell Collection and Storage segmentation.

Placental Stem Cell Collection and Storage Segmentation Breakdown9 items

Application

Stem Cell Therapy

Beauty Products

Other

Types

Hematopoietic Stem Cells (HSCs)

Amniotic Epithelial Cells (AECs)

Mesenchymal stem cells (MSCs)

Others

Regional Insights

Loading chart…

North America dominates the Placental Stem Cell Collection and Storage market with a 35% share, driven by advanced healthcare infrastructure, high adoption rates, and robust R&D investments. The region benefits from mature ecosystems, stringent regulatory frameworks, and increasing patient awareness, particularly in the U.S., where private and public sector funding fuels innovation. Europe follows with a 30% share, supported by favorable policies, public funding, and a well-established biobanking network. Germany and the UK lead due to proactive government initiatives and collaborations between academic institutions and industry players.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 9.5% through 2030, driven by rising middle-class disposable incomes, improving healthcare access, and partnerships between private stem cell banks and hospitals. India and China are pivotal due to their large populations and increasing investments in regenerative medicine. Latin America holds a 10% market share, with Brazil and Mexico showing growth from rising private sector participation and government-backed stem cell research programs. The Middle East & Africa region, at 5%, is emerging due to strategic collaborations with global players and improved healthcare infrastructure in GCC nations, though challenges remain in affordability and awareness.

The Placental Stem Cell Collection and Storage market growth is highly influenced by regional demographics, policy environments, and ecosystem maturity. North America and Europe leverage their technological edge and regulatory clarity, while Asia Pacific benefits from scalable infrastructure and demographic tailwinds. A regional forecast through 2030 highlights Asia Pacific’s potential to bridge the gap, driven by cost-effective solutions and expanding clinical applications.

Competitive Landscape

The Placental Stem Cell Collection and Storage market exhibits a moderately consolidated structure, with a mix of global players and regionally focused firms. The competitive landscape is shaped by pricing strategies, regulatory approvals, and technological differentiation, particularly in cryopreservation and cell viability metrics. Key players leverage certifications (e.g., AABB, ISO) to establish credibility, while regional companies prioritize localized distribution networks. Innovation in sample processing and automation remains a critical growth lever, with strategic emphasis on expanding service portfolios to include therapeutic research collaborations.

Competitive differentiation is driven by technology integration, service customization, and channel partnerships. Companies face challenges from rising compliance costs amid evolving regulatory frameworks, which pressure profit margins. Strategic M&A activity remains active to consolidate regional footprints, while product launches focus on enhancing storage capacity and cell banking solutions. Localization strategies and OEM tie-ups are increasingly adopted to mitigate supply chain risks and strengthen market penetration.

Americord — regional expansion via hospital partnerships

AlphaCord — premium pricing for advanced cryopreservation tech

LifebankUSA — localized service models with flexible pricing tiers

ReeLabs — innovation pipeline targeting cell therapy integration

Cells4Life — OEM tie-ups for sample processing equipment

H&B Group — vertical integration to reduce operational costs

Key Placental Stem Cell Collection and Storage Companies12 items

Americord

AlphaCord

LifebankUSA

ReeLabs

Cells4Life

H&B Group

Boyalife

SALILAI

Qilu Stem Cell

Wuhan Daopei

Eubio

Mayobio

Market Ecosystem

The Placental Stem Cell Collection and Storage ecosystem spans upstream suppliers, midstream service providers, and downstream end users. Value is generated through the integration of specialized technologies, clinical processes, and regulatory frameworks that enable the collection, processing, and long-term preservation of placental stem cells for therapeutic and research applications.

Raw material/component suppliers — provide bioprocessing reagents, cryopreservation solutions, and collection kits

Technology providers — develop storage equipment, automation systems, and bioinformatics platforms for data tracking

Service providers — offer collection, processing, and cryopreservation services at certified biobanks and hospitals

Regulators/standards bodies — oversee compliance with safety, quality, and ethical guidelines for stem cell handling

Distributors/logistics partners — manage cold chain transportation and long-term storage facility maintenance

End users — include hospitals, research institutions, and pharmaceutical companies utilizing stored stem cells

Data/analytics providers — support traceability, inventory management, and clinical outcome tracking systems

Control points in the ecosystem are concentrated among regulators, technology providers, and logistics networks, which dictate compliance standards, infrastructure capabilities, and supply chain reliability. Dependency risks arise from the need for validated processing protocols, certified storage facilities, and cross-industry partnerships. Regional variations in regulatory frameworks and healthcare infrastructure create fragmented adoption patterns, while high switching costs due to proprietary systems and compliance investments reinforce long-term ecosystem dynamics.

Recent Industry Insights

The Placental Stem Cell Collection and Storage industry trends over the past 18 months reflect a dynamic shift driven by technological innovation and strategic collaborations. Key players have prioritized partnerships to expand global reach, such as a 2023 collaboration between a leading stem cell bank and a biotech firm to enhance cryopreservation techniques. Mergers & acquisitions have also accelerated, with a major player acquiring a niche startup specializing in AI-driven sample tracking systems, consolidating market share. On the product/technology front, several companies launched automated collection kits with real-time quality monitoring, addressing contamination risks. Regulatory updates, including Japan’s 2024 revision of stem cell storage guidelines, underscored a push for standardized safety protocols. Meanwhile, consumer demand has shifted toward personalized regenerative therapies, prompting enterprises to bundle storage services with research access. Funding rounds reached a record $150M in 2024, with startups securing capital for scalable storage solutions. Collectively, these advancements signal a maturing industry poised for clinical and commercial growth.

Analyst Overview

Market attractiveness remains high due to rising demand for regenerative therapies and advancements in biobanking technologies. The Placental Stem Cell Collection and Storage market outlook is bolstered by increasing awareness of stem cell banking for future medical applications, particularly in oncology and autoimmune disease treatments.

Competitive intensity is moderate, with a mix of established biobanking firms and niche players innovating in collection protocols and storage solutions. Differentiation hinges on scalability, regulatory compliance, and partnerships with healthcare providers.

Long-term outlook is optimistic, driven by expanding R&D investments and favorable government policies supporting stem cell research. However, market growth will depend on overcoming demand–supply balance challenges, as current collection infrastructure struggles to meet rising global demand.

Innovation landscape highlights3 items

Adoption of AI-driven quality control systems to enhance stem cell viability

Development of eco-friendly cryopreservation techniques

Integration of blockchain for transparent sample tracking

Key risk factors include stringent regulatory scrutiny, ethical debates surrounding placental tissue use, and potential oversupply if clinical adoption lags. Strategic diversification and stakeholder collaboration will be critical to mitigate these risks.

11 items

1. Executive Summary

2. Placental Stem Cell Collection and Storage Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Placental Stem Cell Collection and Storage Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Placental Stem Cell Collection and Storage Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Stem Cell Therapy

6.1.2. Beauty Products

6.1.3. Other

6.2. Global Placental Stem Cell Collection and Storage Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Hematopoietic Stem Cells (HSCs)

6.2.2. Amniotic Epithelial Cells (AECs)

6.2.3. Mesenchymal stem cells (MSCs)

6.2.4. Others

6.3. Global Placental Stem Cell Collection and Storage Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Placental Stem Cell Collection and Storage Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Placental Stem Cell Collection and Storage Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Placental Stem Cell Collection and Storage Market Competition by Key Manufacturers

8.1. Global Placental Stem Cell Collection and Storage Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Placental Stem Cell Collection and Storage: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Americord

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. AlphaCord

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. LifebankUSA

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. ReeLabs

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cells4Life

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. H&B Group

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Boyalife

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. SALILAI

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Qilu Stem Cell

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Wuhan Daopei

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Eubio

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Mayobio

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Placental Stem Cell Collection and Storage Market

Figure 4: Global Placental Stem Cell Collection and Storage Market: Drivers

Figure 5: Global Placental Stem Cell Collection and Storage Market: Challenges

Figure 6: Global Placental Stem Cell Collection and Storage Market: Trends

Figure 7: Global Placental Stem Cell Collection and Storage Market: Opportunity

Figure 8: Global Placental Stem Cell Collection and Storage Market: Restraint

Figure 9: Global Placental Stem Cell Collection and Storage Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Placental Stem Cell Collection and Storage Market Value (USD Million) By Region

Figure 15: Global Placental Stem Cell Collection and Storage Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Placental Stem Cell Collection and Storage Market Value (USD Million) By Region

Figure 23: Global Placental Stem Cell Collection and Storage Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Placental Stem Cell Collection and Storage Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Placental Stem Cell Collection and Storage Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Placental Stem Cell Collection and Storage Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Placental Stem Cell Collection and Storage Market Value (USD Million) By Region

Table 10: Global Placental Stem Cell Collection and Storage Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Placental Stem Cell Collection and Storage Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Placental Stem Cell Collection and Storage Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Placental Stem Cell Collection and Storage Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Americord Basic Information And Sales Area

Table 31: Americord. Products Portfolio

Table 32: AlphaCord Basic Information And Sales Area

Table 33: AlphaCord. Products Portfolio

Table 34: LifebankUSA Basic Information And Sales Area

Table 35: LifebankUSA. Products Portfolio

Table 36: ReeLabs Basic Information And Sales Area

Table 37: ReeLabs. Products Portfolio

Table 38: Cells4Life Basic Information And Sales Area

Table 39: Cells4Life. Products Portfolio

Table 40: H&B Group Basic Information And Sales Area

Table 41: H&B Group. Products Portfolio

Table 42: Boyalife Basic Information And Sales Area

Table 43: Boyalife. Products Portfolio

Table 44: SALILAI Basic Information And Sales Area

Table 45: SALILAI. Products Portfolio

Table 46: Qilu Stem Cell Basic Information And Sales Area

Table 47: Qilu Stem Cell. Products Portfolio

Table 48: Wuhan Daopei Basic Information And Sales Area

Table 49: Wuhan Daopei. Products Portfolio

Table 50: Eubio Basic Information And Sales Area

Table 51: Eubio. Products Portfolio

Table 52: Mayobio Basic Information And Sales Area

Table 53: Mayobio. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Placental Stem Cell Collection and Storage Market Value (USD Million) By Region

Table 59: Global Placental Stem Cell Collection and Storage Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Placental Stem Cell Collection and Storage Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	520.00 million
Revenue forecast in 2033	1.68 billion
Growth rate	CAGR of 15.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Americord; AlphaCord; LifebankUSA; ReeLabs; Cells4Life; H&B Group; Boyalife; SALILAI; Qilu Stem Cell; Wuhan Daopei; Eubio; Mayobio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options